Cargando…
Venous Thromboembolism following Two Doses of COVID-19 mRNA Vaccines in the US Population, 2020–2022
The COVID-19 mRNA vaccine is one of the most effective strategies used to fight against COVID-19. Recently, venous thromboembolism (VTE) events after COVID-19 mRNA vaccination have been reported in various research. Such a concern may hamper the ongoing COVID-19 vaccination campaign. Based on the US...
Autores principales: | Lai, Daoyuan, Zhang, Yan Dora, Lu, Junfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414190/ https://www.ncbi.nlm.nih.gov/pubmed/36016205 http://dx.doi.org/10.3390/vaccines10081317 |
Ejemplares similares
-
No apparent association between mRNA COVID-19 vaccination and venous thromboembolism
por: Nicholson, Matthew, et al.
Publicado: (2022) -
Development of Venous Thromboembolism After COVID-19 mRNA-1273 Vaccine Inoculation
por: Mahgoub, Abdullahi E, et al.
Publicado: (2022) -
Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010-2020
por: Iyer, Geetha S., et al.
Publicado: (2023) -
Prevention of Venous Thromboembolism in 2020 and Beyond
por: Nicholson, Matthew, et al.
Publicado: (2020) -
Thromboembolic events following mRNA vaccines for COVID 19: a case series
por: Serrao, Alessandra, et al.
Publicado: (2022)